Structural Heart Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2028
![]() |
Structural Heart Devices Market |
Clinical care advancements in
cardiac interventions have been made possible by a wide variety of percutaneous
therapy methods. The use of cutting-edge, catheter-based therapies for
structural heart problems has increased during the last ten years. The
effectiveness of many of these non-surgical, catheter-based interventional
techniques has led to a rise in their acceptance among medical professionals
and patients alike. Despite having a lesser volume than coronary treatments,
structural cardiac interventions have become a distinct field of interventional
cardiology.
With improvements in
catheter-based therapy over the past ten years, the adoption of structural
heart therapies has dramatically increased. Due to higher adoption of
tried-and-true techniques, clinical expertise, and the prevalence of valvular
heart diseases, heart valve therapies account for the majority of the Structural
Heart Devices Market revenue in
structural heart interventions.
An estimated 4 million Americans
are thought to have mitral valve insufficiency, and there are 250,000 new cases
of mitral regurgitation each year. The most common cause of VHD in affluent
nations is degenerative valve disease, which has supplanted rheumatic heart
disease. Rheumatic heart disease continues to be the leading cause of VHD in
poor nations, accounting for 33.4 million cases worldwide each year.
The acceptance of such treatments
has increased as a result of the availability of solid clinical evidence for
transcatheter aortic valve replacement. To address the enormous unmet need for
mitral valve treatment, numerous devices made for mitral valve repair and
replacement operations are anticipated to hit the market. More complex
structural heart treatments can now be performed using microinvasive techniques
thanks to developments in interventional imaging, however building the
requisite volume of structural heart procedures to stay knowledgeable and up to
date is difficult in all geographic areas.
Heart Valve
·
Transcatheter Heart Valve
·
Mechanical Heart Valve
·
Surgical Heart Valve
Annuloplasty rings
Occlusion Devices
Top Companies involved are- Abbott Laboratories, Medtronic Plc.,
Edwards Lifesciences Corporation, Boston Scientific Corporation, CryoLife Inc.,
LivaNova Plc., Cook Group Incorporated, Endologix Inc., and W. L. Gore &
Associates
Comments
Post a Comment